Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors.
<h4>Introduction</h4>Hepatic steatosis (HS) negatively impacts transplant outcomes in living liver donors. To date, liver biopsy is preferred for HS evaluation. This study aims to evaluate the measurement of controlled attenuation parameter (CAP) as a diagnostic tool of HS in living live...
Guardado en:
Autores principales: | Dieter Broering, Mohamed Shawkat, Ali Albenmousa, Faisal Abaalkhail, Saleh Alabbad, Waleed Al-Hamoudi, Saad Alghamdi, Saleh Alqahthani, Ahmad Jaafari, Roberto Troisi, Khalid Bzeizi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/562cc6dc058f45cbb183915d3b4a4d78 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The comparison of pancreatic and hepatic steatosis in healthy liver donor candidates
por: Bedriye Koyuncu Sokmen, et al.
Publicado: (2021) -
Effect of COVID-19 on liver abnormalities: a systematic review and meta‐analysis
por: Khalid Bzeizi, et al.
Publicado: (2021) -
Role of PAI-1 in hepatic steatosis and dyslipidemia
por: Joshua A. Levine, et al.
Publicado: (2021) -
Cellular senescence drives age-dependent hepatic steatosis
por: Mikolaj Ogrodnik, et al.
Publicado: (2017) -
Hepatic Steatosis Index Is Associated with Type 1 Diabetes Complications
por: Tripolino C, et al.
Publicado: (2019)